NCT04657874

Bromelain and Escin in the Reduction of Postoperative Sequelae in Periodontal and Implant Surgery

Association Between Bromelain and Escin in the Reduction of Postoperative Sequelae in Periodontal and Implant Surgery: Randomized Clinical Trial, Placebo-controlled, Double-blind

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: University of L'Aquila · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Accepted

Summary

A randomized clinical trial will be performed in parallel, placebo controlled, triple-blind to evaluate the effectiveness of the association Bromelina and Horse-chestnut (titrated in escin) (Noflogo®, Mavenpharma s.r.l., Rome, Italy) in the management of post trauma-surgery following surgery periodontal and implant surgery.

Detailed description

At least 50 volunteers between the ages of 18 and 50, will be enlisted, with the need to perform one of the interventions described above and that fall within the criteria of inclusion. The study will be carried out in accordance with the Helsinki Declaration on In Vivo Studies and will be initiated with the approval of the Internal Review Board of the University of L'Aquila. The protocol follows the guidelines of the CONSORT Statement for parallel studies and will be recorded on the data base clinicaltrials.gov.

Conditions

• Postoperative Pain
• Edema
• Swelling Lips & Face

Interventions

Type	Name	Description
OTHER	Bromelains and Escin Oral Tablet	Supportive care after oral surgery
OTHER	Placebo	Oral tablet without the active principle

Timeline

• Start date: 2020-12-01
• Primary completion: 2021-05-15
• Completion: 2021-05-27
• First posted: 2020-12-08
• Last updated: 2021-09-13

Locations

1 site across 1 country: Italy